ANVS 8-K 2026-10-30

Annovis Bio, Inc. (ANVS) 8-K dated 2026-10-30 — accession 0001104659-26-120732. This URL is the filing, not the ANVS hub.

Annovis Bio, Inc. (ANVS) is a biotechnology company listed on US.

Annovis Bio, Inc. filed a 8-K on 2026-10-30. Accession 0001104659-26-120732.

Cached items: 3.01, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ANVS revenue for 2025-12-31 was $0. Net income was -$28.9M. ANVS currently screens at market cap $80.4M.

Not investment advice. The ANVS SEC hub lists recent forms. The stock page is the research view.